180 related articles for article (PubMed ID: 8766631)
1. [Importance of progress achieved in fundamental biomedical sciences, especially in immunology, for the design of new vaccines].
Louis J
Schweiz Med Wochenschr; 1996 Jul; 126(27-28):1208-9. PubMed ID: 8766631
[TBL] [Abstract][Full Text] [Related]
2. Memory cytolytic T-lymphocytes: induction, regulation and implications for vaccine design.
Baz A; Jackson DC; Kienzle N; Kelso A
Expert Rev Vaccines; 2005 Oct; 4(5):711-23. PubMed ID: 16221072
[TBL] [Abstract][Full Text] [Related]
3. Strategies for designing and optimizing new generation vaccines.
Berzofsky JA; Ahlers JD; Belyakov IM
Nat Rev Immunol; 2001 Dec; 1(3):209-19. PubMed ID: 11905830
[TBL] [Abstract][Full Text] [Related]
4. MHC class II-restricted tumor antigens recognized by CD4+ T cells: new strategies for cancer vaccine design.
Zeng G
J Immunother; 2001; 24(3):195-204. PubMed ID: 11394496
[TBL] [Abstract][Full Text] [Related]
5. HIV/AIDS vaccines: 2007.
Robinson HL
Clin Pharmacol Ther; 2007 Dec; 82(6):686-93. PubMed ID: 17971817
[TBL] [Abstract][Full Text] [Related]
6. Induction of tumor-specific CD4+ and CD8+ T-cell immunity in cervical cancer patients by a human papillomavirus type 16 E6 and E7 long peptides vaccine.
Welters MJ; Kenter GG; Piersma SJ; Vloon AP; Löwik MJ; Berends-van der Meer DM; Drijfhout JW; Valentijn AR; Wafelman AR; Oostendorp J; Fleuren GJ; Offringa R; Melief CJ; van der Burg SH
Clin Cancer Res; 2008 Jan; 14(1):178-87. PubMed ID: 18172269
[TBL] [Abstract][Full Text] [Related]
7. Induction of peripheral CD4+ T-cell tolerance and CD8+ T-cell cross-tolerance by dendritic cells.
Lutz MB; Kurts C
Eur J Immunol; 2009 Sep; 39(9):2325-30. PubMed ID: 19701895
[TBL] [Abstract][Full Text] [Related]
8. [Immunology. Realizable discoveries].
Kabelitz D
Dtsch Med Wochenschr; 1999 Dec; 124(51-52):1570-2. PubMed ID: 10664659
[No Abstract] [Full Text] [Related]
9. The contribution of immunology to the rational design of novel antibacterial vaccines.
Kaufmann SH
Nat Rev Microbiol; 2007 Jul; 5(7):491-504. PubMed ID: 17558425
[TBL] [Abstract][Full Text] [Related]
10. Design and development of synthetic peptide vaccines: past, present and future.
Bijker MS; Melief CJ; Offringa R; van der Burg SH
Expert Rev Vaccines; 2007 Aug; 6(4):591-603. PubMed ID: 17669012
[TBL] [Abstract][Full Text] [Related]
11. Recruitment of different subsets of antigen-presenting cells selectively modulates DNA vaccine-elicited CD4+ and CD8+ T lymphocyte responses.
McKay PF; Barouch DH; Santra S; Sumida SM; Jackson SS; Gorgone DA; Lifton MA; Letvin NL
Eur J Immunol; 2004 Apr; 34(4):1011-20. PubMed ID: 15048711
[TBL] [Abstract][Full Text] [Related]
12. Advances in basic and clinical immunology in 2006.
Chinen J; Shearer WT
J Allergy Clin Immunol; 2007 Aug; 120(2):263-70. PubMed ID: 17590425
[TBL] [Abstract][Full Text] [Related]
13. Cytokine-in-adjuvant steering of the immune response phenotype to HIV-1 vaccine constructs: granulocyte-macrophage colony-stimulating factor and TNF-alpha synergize with IL-12 to enhance induction of cytotoxic T lymphocytes.
Ahlers JD; Dunlop N; Alling DW; Nara PL; Berzofsky JA
J Immunol; 1997 Apr; 158(8):3947-58. PubMed ID: 9103465
[TBL] [Abstract][Full Text] [Related]
14. Lymphocytes in host defense against Pneumocystis carinii.
Beck JM; Harmsen AG
Semin Respir Infect; 1998 Dec; 13(4):330-8. PubMed ID: 9872630
[TBL] [Abstract][Full Text] [Related]
15. Effector and memory T-cell differentiation: implications for vaccine development.
Kaech SM; Wherry EJ; Ahmed R
Nat Rev Immunol; 2002 Apr; 2(4):251-62. PubMed ID: 12001996
[TBL] [Abstract][Full Text] [Related]
16. A decade of vaccines: Integrating immunology and vaccinology for rational vaccine design.
D'Argenio DA; Wilson CB
Immunity; 2010 Oct; 33(4):437-40. PubMed ID: 21029955
[TBL] [Abstract][Full Text] [Related]
17. From immunome to vaccine: epitope mapping and vaccine design tools.
De Groot AS; Martin W
Novartis Found Symp; 2003; 254():57-72; discussion 72-6, 98-101, 250-2. PubMed ID: 14712932
[TBL] [Abstract][Full Text] [Related]
18. A brief history of CD8 T cells.
Masopust D; Vezys V; Wherry EJ; Ahmed R
Eur J Immunol; 2007 Nov; 37 Suppl 1():S103-10. PubMed ID: 17972353
[TBL] [Abstract][Full Text] [Related]
19. Tumor-infiltrating lymphocytes contain higher numbers of type 1 cytokine expressors and DR+ T cells compared with lymphocytes from tumor draining lymph nodes and peripheral blood in patients with cancer of the uterine cervix.
Santin AD; Ravaggi A; Bellone S; Pecorelli S; Cannon M; Parham GP; Hermonat PL
Gynecol Oncol; 2001 Jun; 81(3):424-32. PubMed ID: 11371133
[TBL] [Abstract][Full Text] [Related]
20. Application of flow cytometric beads for simultaneous CD4 and CD8 determinations in HIV-1 infected thalassemia patients.
Tiensiwakul P; Boonmongkol P; Nonsee N; Bunchontevakul S; Desudchit P
J Med Assoc Thai; 2009 Mar; 92(3):398-404. PubMed ID: 19301735
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
